129 related articles for article (PubMed ID: 25474282)
1. [Azathioprine in Crohn's disease therapy--guidance against the background of recent studies].
Schmidt C; Herrlinger K; Siegmund B; Bokemeyer B; Schreiber S; Stallmach A;
Z Gastroenterol; 2014 Dec; 52(12):1423-30. PubMed ID: 25474282
[TBL] [Abstract][Full Text] [Related]
2. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
3. Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on Crohn's disease: a real-life survey in Spain.
Hinojosa J; Gisbert JP; Gomollón F; López San Román A
J Crohns Colitis; 2012 Aug; 6(7):763-70. PubMed ID: 22398092
[TBL] [Abstract][Full Text] [Related]
4. How are Azathioprine and 6-mercaptopurine dosed by gastroenterologists? Results of a survey of clinical practice.
Yip JS; Woodward M; Abreu MT; Sparrow MP
Inflamm Bowel Dis; 2008 Apr; 14(4):514-8. PubMed ID: 18088072
[TBL] [Abstract][Full Text] [Related]
5. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
6. [Response to stopping azathioprine in Crohn's patients on combined treatment with infliximab].
Martín De Carpi J; Varea V
An Pediatr (Barc); 2009 Mar; 70(3):271-7. PubMed ID: 19409244
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease.
Markowitz JF
Rev Gastroenterol Disord; 2003; 3 Suppl 1():S23-9. PubMed ID: 12684586
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
Vilien M; Dahlerup JF; Munck LK; Nørregaard P; Grønbaek K; Fallingborg J
Aliment Pharmacol Ther; 2004 Jun; 19(11):1147-52. PubMed ID: 15153167
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children.
Jeshion WC; Larsen KL; Jawad AF; Piccoli DA; Verma R; Maller ES; Baldassano RN
J Clin Gastroenterol; 2000 Apr; 30(3):294-8. PubMed ID: 10777191
[TBL] [Abstract][Full Text] [Related]
10. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
Mottet C; Schoepfer AM; Juillerat P; Cosnes J; Froehlich F; Kessler-Brondolo V; Seibold F; Rogler G; Vavricka SR; Michetti P
Inflamm Bowel Dis; 2016 Nov; 22(11):2733-2747. PubMed ID: 27760078
[TBL] [Abstract][Full Text] [Related]
11. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
Jacobstein DA; Baldassano RN
Inflamm Bowel Dis; 2005 Feb; 11(2):203-5. PubMed ID: 15677916
[No Abstract] [Full Text] [Related]
12. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
[TBL] [Abstract][Full Text] [Related]
13. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
Panés J; López-Sanromán A; Bermejo F; García-Sánchez V; Esteve M; Torres Y; Domènech E; Piqueras M; Gomez-García M; Gutiérrez A; Taxonera C; Sans M;
Gastroenterology; 2013 Oct; 145(4):766-74.e1. PubMed ID: 23770132
[TBL] [Abstract][Full Text] [Related]
14. Initiating azathioprine for Crohn's disease.
Levesque BG; Loftus EV
Clin Gastroenterol Hepatol; 2012 May; 10(5):460-5. PubMed ID: 22330233
[TBL] [Abstract][Full Text] [Related]
15. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L
Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
[TBL] [Abstract][Full Text] [Related]
16. Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.
Griffiths AM
Inflamm Bowel Dis; 2005 Feb; 11(2):200-2. PubMed ID: 15677915
[No Abstract] [Full Text] [Related]
17. [Drug treatment of Crohn's disease].
van Deventer SJ; Tytgat GN
Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
[TBL] [Abstract][Full Text] [Related]
18. American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
Dassopoulos T; Sultan S; Falck-Ytter YT; Inadomi JM; Hanauer SB
Gastroenterology; 2013 Dec; 145(6):1464-78.e1-5. PubMed ID: 24267475
[No Abstract] [Full Text] [Related]
19. The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts.
Peyrin-Biroulet L; Oussalah A; Roblin X; Sparrow MP
Aliment Pharmacol Ther; 2011 Mar; 33(6):707-13. PubMed ID: 21251032
[TBL] [Abstract][Full Text] [Related]
20. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]